BioPerfectus
 

« Previous article
Protecting Women&rsq...

24th January 2022  Product update: rapidmicrobiology staff writer

Bioperfectus Receives CE Mark for SARS-CoV-2 Antigen Rapid Self-Test


Bioperfectus is pleased to announce that we have obtained CE Mark for our Novel Corona Virus (SARS-CoV-2) Ag Rapid Test Kit (Self-test). This test is a lateral flow test intended for non-prescription home use with self-collected nasal swab specimens. It is used to detect symptomatic individuals who are suspected of COVID-19 or asymptomatic individuals who have had contact with confirmed COVID-19 patients but do not show any symptoms.

Our Novel Corona Virus (SARS-CoV-2) Ag Rapid Test Kit was previously available as a home test in German and Austrian markets since May 20th, 2021. With the CE Mark, our test has received official approval following the traditional registration pathway and can now also be used in markets that have not established regulatory exemption pathways.

As the global economy starts to re-open, individuals or communities can follow the easy instruction of our test and detect whether they are infected with SARS-CoV-2 to avoid the further spread of the disease.

For further information, please send us an inquiry using the 'Request Information' portal below. 


Share on:

Tags:


Date Published: 24th January 2022

Source article link: View

Note: This content has been edited by a rapidmicrobiology staff writer for style and content.


View full company details




BioPerfectus

Address:

China Medical City

China

Tel: +86 021-64193032

Email Supplier

View full company details


Related news from BioPerfectus